Topic: Aranesp
AP News | 2010-01-25 22:16:20
<div id="subtitle">Amgen reports mixed 4Q results for anemia drugs but says revenue from other drugs was stable</div><div><p>Biotechnology company Amgen Inc. said Monday its profit rose 1 percent in the fourth quarter, as the company reported mixed results for its anemia drugs, but said sales of its ...
AP News | 2010-01-22 14:41:56
<div id="subtitle">Amgen to report 4th-quarter results, full-year profit likely near low end of company guidance</div><div><p>Biotechnology company Amgen Inc. is scheduled to report its fourth-quarter and full-year results Monday. The following is a summary of key developments and analyst commentary for the period.</p>< ...
AP News | 2010-01-08 15:34:39
<div id="subtitle">Amgen shares fall as FDA officials urge dosing studies for anemia drugs in kidney patients</div><div><p>Shares of Amgen Inc. fell Thursday over concerns that the Food and Drug Administration's plan to re-examine the safety of anemia drugs could pressure sales of leading anemia treatments Aranesp ...
AP News | 2009-12-22 22:40:10
<div id="subtitle">Amgen says US District Court upholds ruling that blocks Roche from selling Mircera until 2014</div><div><p>Swiss drugmaker Roche will not be allowed to sell its anemia drug Mircera in the U.S. until July 2014 under terms of a settlement with Amgen Inc., the companies said ...
